Bank of America's trading, investment banking and digital expansion drive growth, but rising costs and market volatility pose key challenges.

THC raised its 2026 outlook after Q2 earnings and revenues beat expectations, driven by strong same-facility growth and disciplined expense management.

Tenet Healthcare (THC) is demonstrating improved operational execution as cost discipline across its

The hospital operator recorded a $65 million hit from turbulence on the Affordable Care Act exchanges in the second quarter, but avoided the worse repercussions slamming some of its peers.

The Morning Bull - US Market Morning Update Monday, Jul, 27 2026 US stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up 0.03%, as investors weigh signs of steady US growth against lingering inflation and interest rate questions. New single family home sales reached a 628,000 annual pace in June, up 1.6% for the first monthly rise in three months, which hints that housing is holding up even with higher borrowing costs. At the same time, the US Services PMI...

Tenet Healthcare reported past second-quarter 2026 results showing revenue of US$5,628 million and net income of US$826 million, with basic earnings per share from continuing operations rising to US$9.89 from US$3.16 a year earlier. Alongside these results, the company lifted its full-year 2026 outlook for revenue, net income, and earnings per share while expanding its share repurchase program by US$2 billion. We will now examine how Tenet Healthcare’s stronger full-year 2026 guidance and...

Higher-acuity shift drives guidance hikes across revenue and cash flow.

Tenet Healthcare Corp (THC) reports robust financial performance with significant EBITDA growth and increased guidance for 2026.

Shares of hospital operator Tenet Healthcare (NYSE:THC) jumped 23.5% in the morning session after the company reported second-quarter 2026 results that exceeded analyst expectations and substantially raised its full-year guidance. Tenet posted adjusted earnings per share of $6.12, easily beating the consensus estimate of $4.26. Quarterly revenue also surpassed forecasts, coming in at $5.63 billion compared to the anticipated $5.42 billion. Following the strong performance, the company lifted its

Oil prices continued to retreat on reports that Pakistan, with support from China, was seeking to revive negotiations between the U.S. and Iran.

Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index up 0.6% and the State S

Tenet and HCA Healthcare present Wall Street with different pictures of their operations as the companies report second-quarter earnings.

Tenet Healthcare's (THC) Q2 results topped expectations, with both its hospital and ambulatory surge

This hospital chain seems to be overcoming a problem currently plaguing a peer and rival.

Tenet Healthcare (NYSE:THC) raised its full-year 2026 financial outlook after reporting second-quarter results that exceeded its expectations, supported by hospital volume growth, higher-acuity services, expense-management efforts and continued strength in its ambulatory surgery business. Second-qu

The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Tenet (THC) delivered earnings and revenue surprises of +50.00% and +4.40%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Hospital operator Tenet Healthcare (NYSE:THC) will be reporting results this Friday before market open. Here’s what to look for.

THC's Q2 performance is likely to have witnessed lower patient days, but higher revenue per admission and Ambulatory Care growth could help offset the pressure.

Tenet Healthcare stock has delivered a 172.1% total return over the past 5 years. Yet at around US$194.91, the broader valuation checks still point to the shares looking inexpensive relative to fundamentals. A 172.1% return over 5 years signals that Tenet Healthcare has already rewarded patient shareholders. Any current discount therefore needs to be weighed against the gains that are already on the table. Expectations around the company’s ability to sustain healthy margins and convert...

Why Tenet Healthcare Stock Is Back in Focus Tenet Healthcare (THC) is drawing investor attention after its shares fell 2.15% in the latest session, with the move coming just ahead of the company’s July 24, 2026 earnings report. The upcoming release is expected to show slight changes in earnings per share and revenue. Recent analyst estimate revisions have trimmed EPS expectations, and the stock currently carries a Zacks Rank of #3 (Hold). See our latest analysis for Tenet Healthcare. With...

In the closing of the recent trading day, Tenet Healthcare (THC) stood at $194.91, denoting a -2.15% move from the preceding trading day.

Check out the companies making headlines yesterday:

Shares of hospital operator Tenet Healthcare (NYSE:THC) jumped 4.4% in the afternoon session after the stock continued to rebound as Bank of America reaffirmed its Buy rating.

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the hospital chains industry, including Tenet Healthcare (NYSE:THC) and its peers.

Shares of hospital operator Tenet Healthcare (NYSE:THC) fell 7% in the afternoon session after its stock was dragged down by a sector-wide sell-off as industry peer HCA Healthcare cut its full-year 2026 profit forecast.